600613.SHG Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

Healthcare Pharmaceuticals Shanghai Stock Exchange
7.32 CNY
Close of Nov 5, 2026
4.33 12.77
Market cap
CNY 3.51B
P/E
328.5x
P/B
1.46x
ROE
1.2%
Dividend yield
2.51%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600613.SHG undervalued?

Graham number

The Graham number of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A fundamental analysis

No fundamental analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A yet.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and…

Full company profile